Histone deacetylase 5 blocks neuroblastoma cell differentiation by interacting with N-Myc

Y Sun1, P Y Liu1, C J Scarlett2

  • 1Children's Cancer Institute Australia for Medical Research, Randwick, New South Wales, Australia.

Oncogene
|July 2, 2013
PubMed

Insights

The N-Myc oncoprotein drives neuroblastoma by upregulating histone deacetylase 5 (HDAC5). HDAC5 acts as a co-factor, promoting cancer cell proliferation and blocking differentiation, suggesting HDAC5 inhibitors as a potential therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • N-Myc oncoprotein drives neuroblastoma by disrupting gene expression, leading to blocked cell differentiation and proliferation.
  • Histone deacetylase 5 (HDAC5) is a transcriptional repressor known to inhibit cell differentiation.

Purpose of the Study:

  • To investigate the role of HDAC5 in N-Myc-induced neuroblastoma.
  • To elucidate the molecular mechanisms by which HDAC5 contributes to neuroblastoma pathogenesis.

Main Methods:

  • Genome-wide gene expression analysis.
  • Protein co-immunoprecipitation assays.
  • Analysis of HDAC5 and N-Myc expression in neuroblastoma cells.

Main Results:

  • N-Myc was found to upregulate HDAC5 expression in neuroblastoma cells.
  • HDAC5 repressed NEDD4 and increased Aurora A expression, leading to N-Myc protein upregulation.
  • HDAC5 and N-Myc formed a complex to repress a common gene subset, while HDAC5 also acted independently with SIRT2.
  • HDAC5 blocked neuroblastoma cell differentiation and promoted proliferation.

Conclusions:

  • HDAC5 is identified as a novel co-factor in N-Myc oncogenesis.
  • HDAC5 plays a critical role in promoting neuroblastoma cell proliferation and inhibiting differentiation.
  • HDAC5 inhibitors represent a potential therapeutic strategy for N-Myc-induced neuroblastoma and other c-Myc-related malignancies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...